Development of pneumococcal mastoiditis due to multidrug-resistant serotype 19A despite three doses of 13-valent pneumococcal vaccine

被引：5
|
作者：
Ruck, Richard C. [1 ]
Eberly, Matthew D. [1 ]
机构：
[1] Uniformed Serv Univ Hlth Sci, Dept Pediat Infect Dis, F Edward Hebert Sch Med, Bethesda, MD 20814 USA
来源：
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY | 2012年 / 76卷 / 12期
关键词：
Streptococcus pneumoniae; Mastoiditis; Serotype; 19A; ACUTE OTITIS-MEDIA; CONJUGATE VACCINE; FREQUENCY; EMERGENCE; EFFICACY; DISEASE;
D O I：
10.1016/j.ijporl.2012.08.018
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Acute mastoiditis is a potential complication of acute otitis media (AOM), with Streptococcus pneumoniae historically the most common pathogen isolated. Following the release of the 7-valent pneumococcal conjugate vaccine in 2000, a marked decline in invasive pneumococcal disease and a smaller reduction in pneumococcal AOM were observed, but data regarding its impact on acute mastoiditis are limited. With the recent introduction of the 13-valent pneumococcal conjugate vaccine (PCV13), it is anticipated that pneumococcal AOM and invasive disease will further diminish. We report a case of acute mastoiditis from a multidrug-resistant serotype 19A S. pneumoniae in an immunocompetent child who had received three PCV13 vaccinations. Published by Elsevier Ireland Ltd.
引用
收藏
页码：1849 / 1851
页数：3
相关论文
共 50 条
  • [21] Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012
    Demczuk, Walter H. B.
    Martin, Irene
    Griffith, Averil
    Lefebvre, Brigitte
    McGeer, Allison
    Lovgren, Marguerite
    Tyrrell, Gregory J.
    Desai, Shalini
    Sherrard, Lindsey
    Adam, Heather
    Gilmour, Matthew
    Zhanel, George G.
    CANADIAN JOURNAL OF MICROBIOLOGY, 2013, 59 (12) : 778 - 788
  • [22] 13-valent pneumococcal conjugate vaccine immune sera protects against pneumococcal serotype 1, 3 and 5 bacteremia in a neonatal rat challenge model
    Fernsten, Philip
    Mason, Kathryn W.
    Yu, Xinhong
    Tummolo, Donna
    Belanger, Kelly A.
    Tsao, How
    Zhu, Duzhang
    Cooper, David
    Hagen, Michael
    Jansen, Kathrin U.
    HUMAN VACCINES, 2011, 7 : 75 - 84
  • [23] Cost-Effectiveness of Using 2 vs 3 Primary Doses of 13-Valent Pneumococcal Conjugate Vaccine
    Stoecker, Charles
    Hampton, Lee M.
    Link-Gelles, Ruth
    Messonnier, Mark L.
    Zhou, Fangjun
    Moore, Matthew R.
    PEDIATRICS, 2013, 132 (02) : E324 - E332
  • [24] Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae snerotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil
    Cassiolato, Ana Paula
    Grassi Almeida, Samanta Cristine
    Andrade, Ana Lucia
    Minamisava, Ruth
    de Cunto Brandileone, Maria Cristina
    PLOS ONE, 2018, 13 (11):
  • [25] Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers
    Esposito, Susanna
    Tansey, Susan
    Thompson, Allison
    Razmpour, Ahmad
    Liang, John
    Jones, Thomas R.
    Ferrera, Giuseppe
    Maida, Alessandro
    Bona, Gianni
    Sabatini, Caterina
    Pugni, Lorenza
    Emini, Emilio A.
    Gruber, William C.
    Scott, Daniel A.
    Principi, Nicola
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (06) : 1017 - 1026
  • [26] Parapneumonic Pleural Effusions Caused by Streptococcus pneumoniae Serotype 3 in Children Immunized with 13-Valent Conjugated Pneumococcal Vaccine
    Antachopoulos, Charalampos
    Tsolia, Maria N.
    Tzanakaki, Georgina
    Xirogianni, Athanasia
    Dedousi, Olga
    Markou, Georgia
    Zografou, Sofia-Maria
    Eliades, Andreas
    Kirvassilis, Fotis
    Kesanopoulos, Konstantinos
    Roilides, Emmanuel
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (01) : 81 - 83
  • [27] Epidemiology and Evolution of Invasive Pneumococcal Disease Caused by Multidrug Resistant Serotypes of 19A in the 8 Years After Implementation of Pneumococcal Conjugate Vaccine Immunization in Dallas, Texas
    Techasaensiri, Chonnamet
    Messina, Allison F.
    Katz, Kathy
    Ahmad, Naveed
    Huang, Rong
    McCracken, George H., Jr.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (04) : 294 - 300
  • [28] Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trial
    Okinaka, Keiji
    Akeda, Yukihiro
    Inamoto, Yoshihiro
    Fuji, Shigeo
    Ito, Ayumu
    Tanaka, Takashi
    Kurosawa, Saiko
    Kim, Sung-Won
    Tanosaki, Ryuji
    Yamashita, Takuya
    Ohwada, Chikako
    Kurata, Keiji
    Mori, Takeshi
    Onozawa, Masahiro
    Takano, Kuniko
    Yokoyama, Hiroki
    Koh, Katsuyoshi
    Nagafuji, Koji
    Nakayama, Kazutaka
    Sakura, Toru
    Takahashi, Tsutomu
    Oishi, Kazunori
    Fukuda, Takahiro
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (04) : 482 - 489
  • [29] Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy
    Boccalini, Sara
    Azzari, Chiara
    Resti, Massimo
    Valleriani, Claudia
    Cortimiglia, Martina
    Tiscione, Emilia
    Bechini, Angela
    Bonanni, Paolo
    VACCINE, 2011, 29 (51) : 9521 - 9528
  • [30] Indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with acute respiratory infection despite heterogeneous vaccine coverage: an observational study in Lao People's Democratic Republic
    Chan, Jocelyn
    Lai, Jana Y. R.
    Nguyen, Cattram D.
    Vilivong, Keoudomphone
    Dunne, Eileen M.
    Dubot-Peres, Audrey
    Fox, Kimberley
    Hinds, Jason
    Moore, Kerryn A.
    Nation, Monica L.
    Pell, Casey L.
    Xeuatvongsa, Anonh
    Vongsouvath, Manivanh
    Newton, Paul N.
    Mulholland, Kim
    Satzke, Catherine
    Dance, David A. B.
    Russell, Fiona M.
    BMJ GLOBAL HEALTH, 2021, 6 (06):
12345